Selumetinib Interactions
There are 260 drugs known to interact with selumetinib, along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 77 are major, 182 are moderate, and 1 is minor.
- View all 260 medications that may interact with selumetinib
- View selumetinib alcohol/food interactions (1)
- View selumetinib disease interactions (2)
Most frequently checked interactions
View interaction reports for selumetinib and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall (amphetamine / dextroamphetamine)
- Adriamycin (doxorubicin)
- Advil (ibuprofen)
- Afinitor Disperz (everolimus)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Ambien (zolpidem)
- Amrix (cyclobenzaprine)
- Andexxa (coagulation factor Xa)
- Arava (leflunomide)
- Arcapta (indacaterol)
- Austedo (deutetrabenazine)
- Avelox I.V. (moxifloxacin)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Banzel (rufinamide)
- Barhemsys (amisulpride)
- Belsomra (suvorexant)
- Benemid (probenecid)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Copaxone (glatiramer)
- Cytoxan (cyclophosphamide)
- Emgality (galcanezumab)
- Klonopin (clonazepam)
- Librium (chlordiazepoxide)
- Lyrica (pregabalin)
- Tecfidera (dimethyl fumarate)
- Zonegran (zonisamide)
Selumetinib alcohol/food interactions
There is 1 alcohol/food interaction with selumetinib.
Selumetinib disease interactions
There are 2 disease interactions with selumetinib which include:
Report options
More about selumetinib
- selumetinib consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Koselugo
Koselugo is used to treat neurofibromatosis type 1 (NF1) in children aged 2 and older with ...
Mirdametinib
Mirdametinib (Gomekli) is a treatment for neurofibromatosis type 1 with plexiform neurofibromas ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
